Skip to content

Disc Medicine IRON Cash Flow Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
-$241.6M-13.9%-$212.18M-17.2%-$181.11M-24.6%-$145.39M-24.8%-$116.49M-6.5%
$350K+24.6%$281K+39.8%$201K+60.8%$125K-16.7%$150K-3.8%
$39.92M+16.3%$34.34M+19.9%$28.63M+22.1%$23.45M+22.6%$19.12M+13.7%
-$201.25M-11.6%-$180.39M-9.6%-$164.67M-22.7%-$134.23M-32.0%-$101.7M-8.3%
$82K-91.2%$933K-31.5%$1.36M
-$564.9M-93.2%
$0-100%$7.25M-50.0%$14.49M-33.3%$21.74M-25.0%
$230.85M-51.2%$473.41M+65.8%$285.53M+4.1%$274.37M-38.6%$446.67M+105%
-$219.94M-31.0%
-$201.34M-11.0%-$181.33M-9.2%-$166.03M-22.5%-$135.56M-31.6%-$102.99M-9.1%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Disc Medicine generate?
Disc Medicine (IRON) generated -$201.3M in operating cash flow over the trailing twelve months.
What is Disc Medicine's free cash flow?
After $82.0K of capital expenditures, Disc Medicine's free cash flow was -$201.3M over the trailing twelve months, down 95.5% year over year.
Where does Disc Medicine's cash flow data come from?
Every line is extracted from Disc Medicine's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.